BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 68 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $176,069 | +72356.4% | 61,348 | +45343.0% | 0.00% | – |
| Q4 2022 | $243 | -75.7% | 135 | -76.4% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 573 | -45.6% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 1,054 | -46.3% | 0.00% | – |
| Q1 2022 | $5,000 | -86.5% | 1,962 | -71.5% | 0.00% | – |
| Q4 2021 | $37,000 | -91.1% | 6,896 | -85.9% | 0.00% | – |
| Q3 2021 | $414,000 | -39.6% | 48,898 | -13.0% | 0.00% | – |
| Q2 2021 | $685,000 | -77.9% | 56,200 | -56.1% | 0.00% | -100.0% |
| Q1 2021 | $3,103,000 | +1198.3% | 127,891 | +1612.1% | 0.00% | – |
| Q4 2020 | $239,000 | +177.9% | 7,470 | +161.6% | 0.00% | – |
| Q3 2020 | $86,000 | -49.1% | 2,856 | -28.4% | 0.00% | – |
| Q2 2020 | $169,000 | +92.0% | 3,989 | +12.8% | 0.00% | – |
| Q1 2020 | $88,000 | – | 3,537 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
| Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
| Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
| Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
| Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
| DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
| RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
| Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
| MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
| K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |